Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0G7YG
|
|||
| Former ID |
DIB002905
|
|||
| Drug Name |
ABX-MA1
|
|||
| Synonyms |
Anti-MUC18 MAb, Abgenix
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Melanoma [ICD-11: 2C30; ICD-9: 172] | Discontinued in Phase 1 | [1] | |
| Company |
Abgenix Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cell adhesion molecule (CADM) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800016814) | |||
| REF 2 | Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma. Cancer Res. 2002 Sep 1;62(17):5106-14. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.